Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes

Human Gene Therapy

Volumn 14, Issue 3, 2003, Pages 277-297

  Jacobs, Andreas H ^a,b   Winkeler, Alexandra ^a   Hartung, Markus ^a   Slack, Mark ^a   Dittmar, Claus ^a   Kummer, Christiane ^a   Knoess, Christoph ^a   Galldiks, Norbert ^a   Vollmar, Stefan ^a   Wienhard, Klaus ^a   Heiss, Wolf Dieter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MPI for Neurological Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BICISTRONIC GENE EXPRESSING CASSETTE; CELL KILLING; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL RESEARCH; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DOSE CALCULATION; DOSE RESPONSE; DRUG MONITORING; DRUG SAFETY; ESCHERICHIA COLI; GENE CASSETTE; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FUSION; GENE ISOLATION; GENE LOCATION; GENE THERAPY; GENETIC ENGINEERING; GLIOMA; GLIOSARCOMA; HERPES SIMPLEX VIRUS TYPE 1 AMPLICON VECTOR; HERPES SIMPLEX VIRUS TYPE 1 THYMIDINE KINASE GENE; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; MARKER GENE; MOUSE; MULTICISTRONIC GENE EXPRESSING CASSETTE; NON INVASIVE MEASUREMENT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; RAT; RNA GENE; SENSITIVITY ANALYSIS; SUBCUTANEOUS TISSUE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; GENES, REPORTER; GENETIC VECTORS; RATS; SIMPLEXVIRUS; THYMIDINE KINASE; TOMOGRAPHY, EMISSION-COMPUTED;

ANIMALIA; ESCHERICHIA COLI; HUMAN HERPESVIRUS 1; MUS MUSCULUS; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0037429004     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340360535823     Document Type: Article

References (68)

1. AGHI, M., KRAMM, C.M., CHOU, T.C., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1998). Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J. Natl. Cancer Inst. 90, 370-380.
2. AGHI, M., CHOU, T.C., SULING, K., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1999). Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/CYP2B1 and ganciclovir/HSV-TK gene therapies. Cancer Res. 59, 3861-3865.
3. BELL, J.D., and TAYLOR-ROBINSON, S.D. (2000). Assessing gene expression in vivo: Magnetic resonance imaging and spectroscopy. Gene Ther. 7, 1259-1264.
4. BISCHOFF, J.R., KIRN, D.H., WILLIAMS, A., HEISE, C., HORN, S., MUNA, M., NG, L., NYE, J.A., SAMPSON-JOHANNES, A., FATTAEY, A., and MCCORMICK, F. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373-376.
5. BROOKS, A.I., HALTERMAN, M.W., CHADWICK, C.A., DAVIDSON, B.L., HAAK-FRENDSCHO, M., RADEL, C., PORTER, C., and FEDEROFF, H.J. (1998). Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector. J. Neurosci. Methods 80, 137-147.
6. CHAPPELL, S.A., EDELMAN, G.M., and MAURO, V.P. (2000). A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity. Proc. Natl. Acad. Sci. U.S.A. 97, 1536-1541.
7. CHIOCCA, E.A., and BREAKEFIELD, X.O. (1998). Gene Therapy for Neurological Disorders and Brain Tumors. (Humana Press, Totowa, NJ).
8. CONSTANTINI, L.C., JACOBY, D.R., WANG, S., FRAEFEL, C., BREAKEFIELD, X.O., and ISACSON, O. (1999). Gene transfer to the nigrostriatal system by hybrid HSV/AAV amplicon vectors. Hum. Gene Ther. 10, 2481-2494
9. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1999). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
10. CUNNINGHAM, C., and DAVISON, A.J. (1993). A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197, 116-124.
11. DE FELIPE, P., MARTIN, V., CORTES, M.L., RYAN, M., and IZQUIERDO, M. (1999). Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy. Gene Ther. 6, 198-208.
12. DE FELIPE, P., and IZQUIERDO, M. (2000). Tricistronic and tetracistronic retroviral vectors for gene transfer. Hum. Gene Ther. 11, 1921-1931.
13. DONNELLY, M.L., GANI, D., FLINT, M., MONAGHAN, S., and RYAN, M.D. (1997). The cleavage activities of aphthovirus and cardiovirus 2A proteins. J. Gen. Virol. 78, 13-21.
14. EZZEDDINE, Z.D., MARTUZA, R.L., PLATIKA, D., SHORT, M.P., MALICK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3, 608-614.
15. FRAEFEL, C., SONG, S., LIM, F., LANG, P., YU, L., WANG, Y., WILD, P., and GELLER, A.I. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70, 7190-7197.
16. FRAEFEL, C., JACOBY, D.R., LAGE, C., HILDERBRAND, H., CHOU, J.Y., ALT, F.W., BREAKEFIELD, X.O., and MAJZOUB, J.A. (1997). Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol. Med. 3, 813-825.
17. GAMBHIR, S.S., BARRIO, J.R., WU, L., IYER, M., NAMAVARI, M., SATYAMURTHY, N., BAUER, E., PARRISH, C., MACLAREN, D.C., BORGHEI, A.R., GREEN, L.A., SHARFSTEIN, S., BERK, A.J., CHERRY, S.R., PHELPS, M.E., and HERSCHMAN, H.R. (1998). Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J. Nucl. Med. 39:2003-2011.
18. GAMBHIR, S.S., BARRIO, J.R., PHELPS, M.E., IYER, M., NAMAVARI, M., SATYAMURTHY, N., WU, L., GREEN, L.A., BAUER, E., MACLAREN, D.C., NGUYEN, K., BERK, A.J., CHERRY, S.R., and HERSCHMAN, H.R. (1999). Imaging adeno-viral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. U.S.A. 96, 2333-2338.
19. GAMBHIR, S.S., HERSCHMAN, H.R., CHERRY, S.R., BARRIO, J.R., SATYAMURTHY, N., TOYOKUNI, T., PHELPS, M.E., LARSON, S.M., BALATONI, J., FINN, R., SADELAIN, M., TJUVAJEV, J.G., and BLASBERG, R.G. (2002). Imaging transgene expression with radionuclide technologies. Neoplasia 2, 118-138.
20. GHATTAS, I.R., SANES, J.R., and MAJORS, J.E. (1991). The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11, 5848-5859.
21. GOLDSTEIN, D.J., and WELLER, S.K. (1988). Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 1acZ insertion mutant. J. Virol. 62, 196-205.
22. HARSH, G.R., DEISBOECK, T.S., LOUIS, D.N., HILTON, J., COLVIN, M., SILVER, J.S., QURESHI, N.H., KRACHER, J., FINKELSTEIN, D., CHIOCCA, E.A., and HOCHBERG, F.H. (2000). Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: A gene-marking and neuropathological study. J. Neurosurg. 92, 804-811.
23. HAUBNER, R., AVRIL, N., HANTZOPOULOS, P.A., GANSBACHER, B., and SCHWAIGER, M. (2000). In vivo imaging of herpes simplex virus type I thymidine kinase gene expression: Early kinetics of radiolabelled FIAU. Eur. J. Nucl. Med. 27, 283-291.
24. HEISE, C., HERMISTON, T., JOHNSON, L., BROOKS, G., SAMPSON-JOHANNES, A., WILLIAMS, A., HAWKINS, L., and KIRN, D. (2000). An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat. Med. 6, 1134-1139.
25. 18F]-2-fluoro-2-deoxy-D-glucose. J. Cereb. Blood Flow Metab. 4, 212-223.
26. HOLLON, T. (2000). Researchers and regulators reflect on first gene therapy death. Nat. Med. 6, 6.
27. HOSPERS, G.A., CALOGERO, A., VAN WAARDE, A., DOZE, P., VAALBURG, W., MULDER, N.H., and DE VRIES, E.F. (2000). Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography. Cancer Res. 60, 1488-1491.
28. 18F]Fluoropenciclovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl. Med. 42, 96-105.
29. JACOBS, A., FRAEFEL, C., and BREAKEFIELD, X.O. (1999a). HSV-1 based vectors for gene therapy of neurological diseases and brain tumors: Part I: HSV-1 structure, replication and pathogenesis. Neoplasia 1, 387-401.
30. JACOBS, A., FRAEFEL, C., and BREAKEFIELD, X.O. (1999b). HSV-1 based vectors for gene therapy of neurological diseases and brain tumors: Part II: Vector systems and applications. Neoplasia 1, 402-416.
31. JACOBS, A., DUBROVIN, M., HEWETT, J., SENA-ESTEVES, M., TAN, C., SLACK, M., SADELAIN, M., BREAKEFIELD, X.O., and TJUVAJEV, J.G. (1999c) Functional co-expression of HSV-1 thymidine kinase and green fluorescent protein: Implications for non-invasive imaging of transgene expression. Neoplasia 1, 154-161.
32. JACOBS, A., TJUVAJEV, J.G., DUBROVIN, M., AKHURST, T., BALATONI, J., BEATTIE, B., JOSHI, R., FINN, R., LARSON, S.M., HERRLINGER, U., PECHAN, P.A., CHIOCCA, E.A., BREAKEFIELD, X.O., and BLASBERG, R.G. (2001a). Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res. 61, 2983-2995.
33. 124I]FIAU in cat and man. J. Nucl. Med. 42, 467-475.
34. JACOBS, A., VOGES, J., RESZKA, R., LERCHER, M., GOSSMANN, A., KRACHT, L., KAESTLE, C., WAGNER, R., WIENHARD, K., and HEISS, W.D. (2001c). Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358, 727-729.
35. JANG, S.K., PESTOVA, T.V., HELLEN, C.U., WITHERELL, G.W., and WIMMER, E. (1990). Cap-independent translation of picornavirus RNAs: Structure and function of the internal ribosomal entry site. Enzyme 44, 292-309.
36. KLATZMANN, D., VALERY, C.A., BENSIMON, G., MARRO, B., BOYER, O., MOKHTARI, K., DIQUET, B., SALZMANN, J.L., and PHILIPPON, J. (1998). A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum. Gene Ther. 9, 2595-2604.
37. KRAMM, C.M., CHASE, M., HERRLINGER, U., JACOBS, A., PECHAN, P.A., RAINOV, N.G., SENA-ESTEVES, M., AGHI, M., BARNETT, F.H., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1997). Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Hum. Gene Ther. 8, 2057-2068.
38. LAUFS, S., KIM, S.H., KIM, S., BLAU, N., and THONY, B. (2000). Reconstitution of a metabolic pathway with triple-cistronic IRES-containing retroviral vectors for correction of tetrahydrobiopterin deficiency. J. Gene Med. 2, 22-31.
39. LOIMAS, S., WAHLFORS, J., and JANNE, J. (1998). Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: New tool for gene transfer studies and gene therapy. Biotechniques 24, 614-618.
40. MARTINEZ-SALAS, E. (1999). Internal ribosome entry site biology and its use in expression vectors. Curr. Opin. Biotechnol. 10, 458 -464.
41. MARTUZA, R.L., MALICK, A., MARKERT, J.M., RUFFNER, K.L., and COEN, D.M. (1991). Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 25, 854-856.
42. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
43. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. U.S.A. 89, 33-37.
44. OWENS, G.C., CHAPPELL, S.A., MAURO, V.P., and EDELMAN, G.M. (2001). Identification of two short internal ribosome entry sites selected from libraries of random oligonucleotides. Proc. Natl. Acad. Sci. U.S.A. 98, 1471-1476
45. PALMENBERG, A.C. (1990). Proteolytic processing of picornaviral polyprotein. Annu. Rev. Microbiol. 44, 603-623.
46. PHELPS, M.E. (2000). PET: The merging of biology and imaging into molecular imaging. J. Nucl. Med. 41, 661-681.
47. RAINOV, N.G. (2000). A phase III clinical evaluation of herpes simplex virus type i thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 11, 2389-2401.
48. RAM, Z., CULVER, K.W., OSHIRO, E.M., VIOLA, J.J., DEVROOM, H.L., OTTO, E., LONG, Z., CHIANG, Y., MCGARRITY, G.J., MUUL, L.M., KATZ, D., BLAESE, R.M., and OLDFIELD, E.H. (1997). Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3, 1354-1361.
49. ROGULSKI, K.R., KIM, J.H., KIM, S.H., and FREYTAG, S.O. (1997). Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther. 8, 73-85.
50. ROGULSKI, K.R., WING, M.S., PAIELLI, D.L., GILBERT, J.D., KIM, J.H., and FREYTAG, S.O. (1997). Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. Hum. Gene Ther. 11, 67-76.
51. RYAN, M.D., and FLINT, M. (1997). Virus-encoded proteinases of the picomavirus super-group. J. Gen. Virol. 78, 699-723.
52. SAITO, Y., PRICE, R.W., ROTTENBERG, D.A., FOX, J.J., SU, T.L., WATANABE, K.A., and PHILIPS, F.S. (1982). Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science 217, 1151-1153.
53. SAUERBREY, A., MCPHERSON, J.P., ZHAO, S.C., BANERJEE, D., and BERTINO, J.R. (1999). Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside. Hum. Gene Ther. 10, 2495-2504.
54. SHAND, N., WEBER, F., MARIANI, L., BERNSTEIN, M., GIANELLA-BORRADORI, A., LONG, Z., SORENSEN, A.G., and BARBIER, N. (1999). A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GL1328 European-Canadian Study Group. Hum. Gene Ther. 10, 2325-2335.
55. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897-916.
56. STAAL, F.J., BAKKER, A.Q., VERKUIJLEN, M., VAN OORT, E, and SPIIS, H. (1996). Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: A method to select producer cells and follow transduced target cells. Cancer Gene Ther. 3, 345-351.
57. STEGMAN, L.D., REHEMTULLA, A., BEATTIE, B., KIEVIT, E., LAWRENCE, T.S., BLASBERG, R.G., TJUVAJEV, J.G., and ROSS, B.D. (1999). Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 96, 9821-9826.
58. TJUVAJEV, J.G., STOCKHAMMER, G., DESAI, R., UEHARA, H., WATANABE, K., GANSBACHER, B., and BLASBERG, R.G. (1995). Imaging the expression of transfected genes in vivo. Cancer Res. 55, 6126-6132.
59. TJUVAJEV, J.G., FINN, R., WATANABE, K., JOSHI, R., OKU, T., KENNEDY, J., BEATTIE, B., KOUTCHER, J., LARSON, S., and BLASBERG, R.G. (1996). Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res. 56, 4087-4095.
60. TJUVAJEV, J.G., AVRIL, N., OKU, T., SASAJIMA, T., MIYAGAWA, T., JOSHI, R., SAFER, M., BEATTIE, B., DIRESTA, G., DAGHIGHIAN, F., AUGENSEN, F., KOUTCHER, J., ZWEIT, J., HUMM, J., LARSON, S.M., FINN, R., and BLASBERG, R. (1998). Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58, 4333-4341.
61. TJUVAJEV, J.G., CHEN, S.H., JOSHI, A., JOSHI, R., GUO, Z.S., BALATONI, J., BALLON, D., KOUTCHER, J., FINN, R., WOO, S.L., and BLASBERG, R.G. (1999a). Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59, 5186-5193.
62. TJUVAJEV, J.G., JOSHI, A., CALLEGARI, J., LINDSLEY, L., JOSHI, R., BALATONI, J., FINN, R., LARSON, S.M., SADELAIN, M., and BLASBERG, R.G. (1999b). A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1, 315-320.
63. VOGES, J., WEBER, F., RESZKA, R., STURM, V., JACOBS, A., HEISS, W.D., WIESTLER, O., and KAPP, J.F. (2002). Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme. Hum. Gene Ther. 13, 675-685.
64. WEISSLEDER, R., MOORE, A., MAHMOOD, U., BHORADE, R., BENVENISTE, H., CHIOCCA, E.A., and BASILION, J.P. (2000). In vivo magnetic resonance imaging of transgene expression. Nat. Med. 6, 351-355.
65. WEIZSAECKER, M., DEEN, D.F., ROSENBLUM, M.L., HOSHINO, T., GUTIN, P.H., and BARKER, M. (1981). The 9L rat brain tumor: Description and application of an animal model. J. Neurol. 224, 183-192.
66. WILDNER, O. (1999), In situ use of suicide genes for therapy of brain tumours. Ann. Med. 31, 421-429.
67. YOUNG, A.B. (1998). Neurological disorders: An overwiew. In Gene Therapy for Neurological Disorders and Brain Tumors. E.A. Chiocca, X.O. Breakefield, eds. (Humana Press, Totowa, NJ) pp. 341-343.
68. YU, Y., ANNALA, A.J., BARRIO, J.R., TOYOKUNI, T., SATYAMURTHY, N., NAMAVARI, M., CHERRY, S.R., PHELPS, M.E., HERSCHMAN, H.R., and GAMBHIR, S.S. (2000). Quantification of target gene expression by imaging reporter gene expression in living animals. Nat. Med. 6, 933-937.